Find clinical trials for Lymphoma in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Seattle, WA, USA:
a standard 3+3 design. Once the maximum tolerated dose (MTD) is determined amongst patients with relapsed or refractory grade 1-3a follicular lymphoma...
Phase 1, Phase 2
Seattle, Washington, United States and 2 other locations
SC262-101 is a Phase 1 study to evaluate SC262 safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory bioma...
Phase 1
Seattle, Washington, United States and 2 other locations
This phase II trial studies how well pembrolizumab with rituximab or obinutuzumab work in treating patients with follicular lymphoma or diff...
Phase 2
Seattle, Washington, United States
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Seattle, Washington, United States and 59 other locations
This phase I/II trial studies the safety of acalabrutinib and axicabtagene ciloleucel in treating patients with B-cell lymphoma. Acalabrutin...
Phase 1, Phase 2
Seattle, Washington, United States
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Tacoma, Washington, United States and 70 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Seattle, Washington, United States and 215 other locations
The purpose of this study is to define the recommended Phase 2 Dose, safety, tolerability, immunogenicity, and preliminary efficacy of EO2463 during...
Phase 1, Phase 2
Seattle, Washington, United States and 9 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Seattle, Washington, United States and 94 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Seattle, Washington, United States and 67 other locations
Clinical trials
Research sites
Resources
Legal